PanTher Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- PanTher Therapeutics's estimated annual revenue is currently $1.6M per year.
- PanTher Therapeutics's estimated revenue per employee is $77,500
Employee Data
- PanTher Therapeutics has 21 Employees.
- PanTher Therapeutics grew their employee count by 24% last year.
PanTher Therapeutics's People
Name | Title | Email/Phone |
---|
PanTher Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is PanTher Therapeutics?
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. Our highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions us to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
keywords:N/AN/A
Total Funding
21
Number of Employees
$1.6M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.4M | 22 | -4% | N/A |
#2 | $5.1M | 22 | -4% | N/A |
#3 | $3.4M | 24 | 9% | N/A |
#4 | $4.1M | 24 | -4% | N/A |
#5 | N/A | 24 | -23% | N/A |